271 related articles for article (PubMed ID: 25434284)
1. The potential of class 3 semaphorins as both targets and therapeutics in cancer.
Mishra R; Kumar D; Tomar D; Chakraborty G; Kumar S; Kundu GC
Expert Opin Ther Targets; 2015 Mar; 19(3):427-42. PubMed ID: 25434284
[TBL] [Abstract][Full Text] [Related]
2. The semaphorins and their receptors as modulators of tumor progression.
Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
Drug Resist Updat; 2016 Nov; 29():1-12. PubMed ID: 27912840
[TBL] [Abstract][Full Text] [Related]
3. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
4. Semaphorins in cancer.
Neufeld G; Shraga-Heled N; Lange T; Guttmann-Raviv N; Herzog Y; Kessler O
Front Biosci; 2005 Jan; 10():751-60. PubMed ID: 15569615
[TBL] [Abstract][Full Text] [Related]
5. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.
Kigel B; Varshavsky A; Kessler O; Neufeld G
PLoS One; 2008 Sep; 3(9):e3287. PubMed ID: 18818766
[TBL] [Abstract][Full Text] [Related]
6. Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer.
Mastrantonio R; You H; Tamagnone L
Theranostics; 2021; 11(7):3262-3277. PubMed ID: 33537086
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin signaling in vascular and tumor biology.
Neufeld G; Lange T; Varshavsky A; Kessler O
Adv Exp Med Biol; 2007; 600():118-31. PubMed ID: 17607951
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin as a therapeutic target for cancer.
Bandopadhyay M; Bulbule A; Butti R; Chakraborty G; Ghorpade P; Ghosh P; Gorain M; Kale S; Kumar D; Kumar S; Totakura KV; Roy G; Sharma P; Shetti D; Soundararajan G; Thorat D; Tomar D; Nalukurthi R; Raja R; Mishra R; Yadav AS; Kundu GC
Expert Opin Ther Targets; 2014 Aug; 18(8):883-95. PubMed ID: 24899149
[TBL] [Abstract][Full Text] [Related]
9. The role of semaphorins in cardiovascular diseases: Potential therapeutic targets and novel biomarkers.
Yin Z; Zhang J; Xu S; Liu J; Xu Y; Yu J; Zhao M; Pan W; Wang M; Wan J
FASEB J; 2022 Oct; 36(10):e22509. PubMed ID: 36063107
[TBL] [Abstract][Full Text] [Related]
10. Class IV semaphorins in disease pathogenesis.
Nojima S
Pathol Int; 2022 Oct; 72(10):471-487. PubMed ID: 36066011
[TBL] [Abstract][Full Text] [Related]
11. Semaphorins in angiogenesis and tumor progression.
Neufeld G; Sabag AD; Rabinovicz N; Kessler O
Cold Spring Harb Perspect Med; 2012 Jan; 2(1):a006718. PubMed ID: 22315716
[TBL] [Abstract][Full Text] [Related]
12. The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases.
Wu M; Li J; Gao Q; Ye F
Expert Opin Ther Targets; 2016 Jul; 20(7):885-901. PubMed ID: 26732941
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns and pathogenesis of Semaphorin class 4 subfamily proteins in solid tumors.
Jiang D; Chen X; Li X; Qiu J; Xu P; Li X
Neoplasma; 2024 Feb; 71(1):1-12. PubMed ID: 38295103
[TBL] [Abstract][Full Text] [Related]
14. Class-3 Semaphorins and Their Receptors: Potent Multifunctional Modulators of Tumor Progression.
Toledano S; Nir-Zvi I; Engelman R; Kessler O; Neufeld G
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696103
[No Abstract] [Full Text] [Related]
15. Relation of immune semaphorin/plexin signaling to carcinogenesis.
Műzes G; Sipos F
Eur J Cancer Prev; 2014 Sep; 23(5):469-76. PubMed ID: 24922268
[TBL] [Abstract][Full Text] [Related]
16. The role of the semaphorins in cancer.
Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
Cell Adh Migr; 2016 Nov; 10(6):652-674. PubMed ID: 27533782
[TBL] [Abstract][Full Text] [Related]
17. Semaphorin signaling in bone.
Verlinden L; Vanderschueren D; Verstuyf A
Mol Cell Endocrinol; 2016 Sep; 432():66-74. PubMed ID: 26365296
[TBL] [Abstract][Full Text] [Related]
18. Full-Length Semaphorin-3C Is an Inhibitor of Tumor Lymphangiogenesis and Metastasis.
Mumblat Y; Kessler O; Ilan N; Neufeld G
Cancer Res; 2015 Jun; 75(11):2177-86. PubMed ID: 25808871
[TBL] [Abstract][Full Text] [Related]
19. Semaphorins and tumor angiogenesis.
Serini G; Maione F; Giraudo E; Bussolino F
Angiogenesis; 2009; 12(2):187-93. PubMed ID: 19266292
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin signals tweaking the tumor microenvironment.
Muratori C; Tamagnone L
Adv Cancer Res; 2012; 114():59-85. PubMed ID: 22588056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
